Cell mediated immunity to human solid tumors

in vitro detection by lymphocyte blastogenic responses to cell associated and solubilized tumor antigens

G. M. Mavligit, J. U. Gutterman, C. M. McBride, Evan M Hersh

Research output: Chapter in Book/Report/Conference proceedingChapter

51 Citations (Scopus)

Abstract

Cell mediated immunity to human solid tumors could be demonstrated in vitro by the lymphocyte blastogenesis method. Blastogenic responses to unseparated autochthonous tumor cells were positive in 19 of 29 patients. The intensity of response was dose related, and the maximum response required a tumor cell lymphocyte ratio of l:l. The intensity of response was also correlated inversely with the extent of disease. The effect of serum from cancer patients on such responses in vitro was complex. It could be both inhibitory or facilitory and did not correlate with the extent of the disease. Separation of viable from nonviable tumor cells by specific density solution (Ficoll Hypaque), and their respective treatment with irradiation, mitomycin C, or nothing, showed that viable tumor cells were superior to nonviable cells and irradiation was superior to mitomycin C in inducing lymphocyte blastogenesis. Irradiated viable tumor cells appeared to be the material of choice in the study of lymphocyte blastogenic response to cell associated tumor antigen. Soluble antigen, extracted with 3M KCl induced vigorous blastogenic responses in autologous lymphocytes, but no such stimulation occurred among normal allogeneic lymphocytes. An immunologic difference between cell associated antigens and their soluble form was hypothesized.

Original languageEnglish (US)
Title of host publicationNational Cancer Institute Monograph
Pages167-176
Number of pages10
Volume37
StatePublished - 1973
Externally publishedYes

Fingerprint

Neoplasm Antigens
Cellular Immunity
Lymphocytes
Neoplasms
Mitomycin
Lymphocyte Activation
Diatrizoate
Antigens
Ficoll
In Vitro Techniques
Cell Count
Serum

ASJC Scopus subject areas

  • Cancer Research

Cite this

Mavligit, G. M., Gutterman, J. U., McBride, C. M., & Hersh, E. M. (1973). Cell mediated immunity to human solid tumors: in vitro detection by lymphocyte blastogenic responses to cell associated and solubilized tumor antigens. In National Cancer Institute Monograph (Vol. 37, pp. 167-176)

Cell mediated immunity to human solid tumors : in vitro detection by lymphocyte blastogenic responses to cell associated and solubilized tumor antigens. / Mavligit, G. M.; Gutterman, J. U.; McBride, C. M.; Hersh, Evan M.

National Cancer Institute Monograph. Vol. 37 1973. p. 167-176.

Research output: Chapter in Book/Report/Conference proceedingChapter

Mavligit, GM, Gutterman, JU, McBride, CM & Hersh, EM 1973, Cell mediated immunity to human solid tumors: in vitro detection by lymphocyte blastogenic responses to cell associated and solubilized tumor antigens. in National Cancer Institute Monograph. vol. 37, pp. 167-176.
Mavligit, G. M. ; Gutterman, J. U. ; McBride, C. M. ; Hersh, Evan M. / Cell mediated immunity to human solid tumors : in vitro detection by lymphocyte blastogenic responses to cell associated and solubilized tumor antigens. National Cancer Institute Monograph. Vol. 37 1973. pp. 167-176
@inbook{b057a5dcbdca4d6d99df2de2f031825f,
title = "Cell mediated immunity to human solid tumors: in vitro detection by lymphocyte blastogenic responses to cell associated and solubilized tumor antigens",
abstract = "Cell mediated immunity to human solid tumors could be demonstrated in vitro by the lymphocyte blastogenesis method. Blastogenic responses to unseparated autochthonous tumor cells were positive in 19 of 29 patients. The intensity of response was dose related, and the maximum response required a tumor cell lymphocyte ratio of l:l. The intensity of response was also correlated inversely with the extent of disease. The effect of serum from cancer patients on such responses in vitro was complex. It could be both inhibitory or facilitory and did not correlate with the extent of the disease. Separation of viable from nonviable tumor cells by specific density solution (Ficoll Hypaque), and their respective treatment with irradiation, mitomycin C, or nothing, showed that viable tumor cells were superior to nonviable cells and irradiation was superior to mitomycin C in inducing lymphocyte blastogenesis. Irradiated viable tumor cells appeared to be the material of choice in the study of lymphocyte blastogenic response to cell associated tumor antigen. Soluble antigen, extracted with 3M KCl induced vigorous blastogenic responses in autologous lymphocytes, but no such stimulation occurred among normal allogeneic lymphocytes. An immunologic difference between cell associated antigens and their soluble form was hypothesized.",
author = "Mavligit, {G. M.} and Gutterman, {J. U.} and McBride, {C. M.} and Hersh, {Evan M}",
year = "1973",
language = "English (US)",
volume = "37",
pages = "167--176",
booktitle = "National Cancer Institute Monograph",

}

TY - CHAP

T1 - Cell mediated immunity to human solid tumors

T2 - in vitro detection by lymphocyte blastogenic responses to cell associated and solubilized tumor antigens

AU - Mavligit, G. M.

AU - Gutterman, J. U.

AU - McBride, C. M.

AU - Hersh, Evan M

PY - 1973

Y1 - 1973

N2 - Cell mediated immunity to human solid tumors could be demonstrated in vitro by the lymphocyte blastogenesis method. Blastogenic responses to unseparated autochthonous tumor cells were positive in 19 of 29 patients. The intensity of response was dose related, and the maximum response required a tumor cell lymphocyte ratio of l:l. The intensity of response was also correlated inversely with the extent of disease. The effect of serum from cancer patients on such responses in vitro was complex. It could be both inhibitory or facilitory and did not correlate with the extent of the disease. Separation of viable from nonviable tumor cells by specific density solution (Ficoll Hypaque), and their respective treatment with irradiation, mitomycin C, or nothing, showed that viable tumor cells were superior to nonviable cells and irradiation was superior to mitomycin C in inducing lymphocyte blastogenesis. Irradiated viable tumor cells appeared to be the material of choice in the study of lymphocyte blastogenic response to cell associated tumor antigen. Soluble antigen, extracted with 3M KCl induced vigorous blastogenic responses in autologous lymphocytes, but no such stimulation occurred among normal allogeneic lymphocytes. An immunologic difference between cell associated antigens and their soluble form was hypothesized.

AB - Cell mediated immunity to human solid tumors could be demonstrated in vitro by the lymphocyte blastogenesis method. Blastogenic responses to unseparated autochthonous tumor cells were positive in 19 of 29 patients. The intensity of response was dose related, and the maximum response required a tumor cell lymphocyte ratio of l:l. The intensity of response was also correlated inversely with the extent of disease. The effect of serum from cancer patients on such responses in vitro was complex. It could be both inhibitory or facilitory and did not correlate with the extent of the disease. Separation of viable from nonviable tumor cells by specific density solution (Ficoll Hypaque), and their respective treatment with irradiation, mitomycin C, or nothing, showed that viable tumor cells were superior to nonviable cells and irradiation was superior to mitomycin C in inducing lymphocyte blastogenesis. Irradiated viable tumor cells appeared to be the material of choice in the study of lymphocyte blastogenic response to cell associated tumor antigen. Soluble antigen, extracted with 3M KCl induced vigorous blastogenic responses in autologous lymphocytes, but no such stimulation occurred among normal allogeneic lymphocytes. An immunologic difference between cell associated antigens and their soluble form was hypothesized.

UR - http://www.scopus.com/inward/record.url?scp=0015874536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015874536&partnerID=8YFLogxK

M3 - Chapter

VL - 37

SP - 167

EP - 176

BT - National Cancer Institute Monograph

ER -